Dermata Therapeutics (DRMA) Interest Expenses (2020 - 2025)
Dermata Therapeutics (DRMA) posted quarterly Interest Expenses of $700000.0 for Q1 2025, down 22.22% year-over-year from $900000.0 in Q1 2024, and down 46.15% quarter-over-quarter from $1.3 million in Q4 2024.
Dermata Therapeutics (DRMA) Interest Expenses (2020 - 2025) Analysis & Trends
Dermata Therapeutics' Interest Expenses history runs 6 years deep, the most recent figure standing at $700000.0 for Q1 2025.
- In Q1 2025, Interest Expenses fell 22.22% year-over-year to $700000.0; the TTM figure through Dec 2025 stood at $700000.0 (down 87.5% YoY), while the FY2025 annual figure was $700000.0, down 91.27% from the prior year.
- Interest Expenses for Q1 2025 stood at $700000.0, down from $1.3 million in the prior quarter.
- The five-year high for Interest Expenses was $1.8 million in Q3 2024, with the low at $651.0 in Q3 2021.
- The 5-year median for Interest Expenses is $450000.0 (2022), against an average of $667460.9.
- The sharpest annual moves came in 2021 and 2024: Interest Expenses sank 98.86% in 2021, then jumped 907.75% in 2024.
- Dermata Therapeutics' Interest Expenses stood at $651.0 in 2021, then jumped by 30621.97% to $200000.0 in 2022, then slumped by 35.5% to $129000.0 in 2023, then surged by 907.75% to $1.3 million in 2024, then plunged by 46.15% to $700000.0 in 2025.
- Business Quant data shows DRMA's Interest Expenses at $700000.0 in Q1 2025, $1.3 million in Q4 2024, and $1.8 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 82.05 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 20.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 93.62 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -4.89 Mn |
| 10 | Dermata Therapeutics | 5.33 Mn | 5.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 700,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Dec 31, 2024 | 1.30 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 1.60 Mn |
| Jun 30, 2024 | 1.60 Mn |
| Mar 31, 2024 | 900,000.00 |
| Mar 31, 2024 | 900,000.00 |
| Dec 31, 2023 | 129,000.00 |
| Dec 31, 2023 | 129,000.00 |
| Mar 31, 2022 | 200,000.00 |
| Mar 31, 2022 | 200,000.00 |
| Sep 30, 2021 | 651.00 |
| Sep 30, 2021 | 651.00 |
| Jun 30, 2021 | 1,823.00 |
| Jun 30, 2021 | 1,823.00 |
| Mar 31, 2021 | 43,135.00 |
| Mar 31, 2021 | 43,135.00 |